Friday, October 2, 2020

Dr Reddy#39;s seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V

Dr Reddy#39;s seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V The Indian pharma giant has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution.

from Moneycontrol Business News https://ift.tt/3n9mTRz

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...